Tacrolimus and Estring drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Estring (estradiol). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Estring. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,161 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Estring?

Estring has active ingredients of estradiol. eHealthMe is studying from 5,474 Estring users. Check the latest studies of Estring.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

13 people who take Tacrolimus and Estring together, and have interactions are studied.

Tacrolimus and Estring drug interactions.

What are the common drug interactions of Tacrolimus and Estring, by gender? *:

female:

Drug ineffective
Pain
Haemoglobin decreased
Headache (pain in head)
Procedural nausea
Procedural vomiting
Tendonitis (a condition that causes pain and swelling of tendons)
Therapeutic response decreased (less preventive response)
Urinary tract infection
Blood cholesterol increased

male:

n/a

What are the common drug interactions of Tacrolimus and Estring, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Headache (pain in head)
Pain
Procedural nausea
Procedural vomiting
Therapeutic response decreased (less preventive response)
Urinary tract infection
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Back pain
Bone marrow failure
Claustrophobia (fear of having no escape and being closed in small spaces)

60+:

Chest pain
Fluid intake reduced
Tendonitis (a condition that causes pain and swelling of tendons)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 53.85%
Pain: 2 people, 15.38%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 15.38%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 15.38%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 1 person, 7.69%
Immune System Disorder: 1 person, 7.69%
Chronic Renal Failure (kidney failure): 1 person, 7.69%
Chronic Kidney Disease: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Estring?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously